RTi3 2023 Inquire Keynote

Description 

Every year there are approximately 9.6 million deaths caused by cancer globally. Radiotherapy (RT) plays a key role in cancer management, and it is recommended as part of treatment for more than 50% of cancer patients. As the number of new cases of cancer continues to rise, the demand for RT services has been increasing constantly. In the last decade, there have been rapid changes and progressive developments in the technology used for RT planning and delivery.

Besides implementing the latest technology with cutting edge equipment, it is essential to continue developing and advancing the RT professional practice through clinical trials in order to facilitate the safe delivery of evidence-based advanced RT which meets with the service demand. Radiation therapists (RTT) are responsible for planning and delivering RT treatments and play a non-replaceable role in cancer patients’ RT pathways. RTTs are the constant and familiar professionals for the patient and well aware of their history. They advise on all aspects of RT and this reduces patients’ anxiety at times when they are frightened and vulnerable.

The unique professional perceptive from RTTs is an extremely valuable enabler for designing and executing multi-professional clinical trials with a patient-centered focus. This presentation will include a number of examples showcasing the roles and impact of RTTs in developing clinical trials and evidence-based medicine within radiation oncology.